Precision of IMED-4 Lung Fluid Measurements
NCT02187770
Acute Heart Failure Syndrome, Dyspnea
Boston, Massachusetts, United States
View Trial DetailsNCT Number: NCT02111525
The purpose of this study is to determine the distribution of lung fluid status as reported by the IMED-4 system in patients presenting to the emergency department or urgent care facility with shortness of breath.
Looking for future studies?
Notify Me45 year and older
All sexes
Observational
Wayne State University Hospital, Detroit, Michigan, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 1 year
The IMED 4 is a new device designed to measure the lung fluid status by assessing how wet or dry the lungs are
Intersection Medical, Inc.
Industry
Acronym: FLOOD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02187770
Acute Heart Failure Syndrome, Dyspnea
Boston, Massachusetts, United States
View Trial DetailsNCT05352490
Decompensated Heart Failure ; COPD Exacerbation, Dyspnea
Monastir, Tunisia
View Trial DetailsNCT04886128
Acute Heart Failure, Cardiovascular Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT07656610
COVID-19, COVID-19 Pneumonia
Çorum, Turkey (Türkiye)
View Trial Details